Core Viewpoint - Meritage Homes, the fifth-largest public homebuilder in the U.S., reinforced its commitment to community building and philanthropy in 2025, contributing over $4 million to various initiatives aimed at education, disaster relief, food security, and housing support [1][2][3]. Philanthropic Contributions - The company allocated $2 million for K-12 education initiatives and donated an additional $2 million through its philanthropic foundation, Meritage Cares, along with in-kind contributions [1]. - Meritage contributed over $600,000 to assist families affected by California wildfires and severe flooding in Texas, providing emergency relief and long-term recovery resources [2]. - An investment of nearly $450,000 was made to fund academic scholarships for students and support early careers in construction [3]. Food Security and Shelter Initiatives - Meritage donated $250,000 to No Child Hungry and employees volunteered over 2,000 hours to pack over 465,000 meal kits for children in need [4]. - The company continued its support of the Arizona Housing Fund for the fifth consecutive year to promote affordable housing initiatives [5]. Environmental and Community Support - A contribution of $300,000 was made to the Arbor Day Foundation to support reforestation and water conservation efforts [6]. - Meritage built and donated two mortgage-free homes to military families through its partnership with Operation Homefront, aiding 22 families in total [7]. Company Overview - Meritage Homes is recognized for its energy-efficient and affordable housing solutions, operating across multiple states including Arizona, California, and Texas [9]. - The company has delivered over 200,000 homes in its 40-year history and has received numerous awards for its commitment to quality construction and customer experience [10].

HIGHLIGHTS 5,983 m of infill drilling completed (3,704 m of new results) on 10-m drill spacing in 62 drill holes from August 2025, representing ~44% of the total planned 13,000-m infill program Highlights include: 8.56 g/t Au over 8.5m from 60.5m depth, 16.95 g/t Au over 4.0m from 80m depth (including 130.32 g/t Au over 0.5m from 83.5m depth), and 9.32 g/t Au over 6.0m from 58m depthResults to date continue to be broadly consistent with modelled reserve stopes, indicate potential for upside mineralization i ...

BOSTON, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that Claire Mazumdar, PhD, MBA, Chief Executive Officer, will present at the J.P. Morgan 2026 Healthcare Conference on Monday, January 12, 2026 at 11:15 a.m. PT. A live webcast of the presentation will be accessible through the Investor Relations section of Bicara’s website unde ...

TORONTO , Dec. 15, 2025 (GLOBE NEWSWIRE) -- Altus Group Limited (“Altus Group” or the “Company”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, announced today that, in connection with its ongoing substantial issuer bid (the “SIB”) to purchase for cancellation up to C$350,000,000 in value of its common shares (the “Shares”), the Ontario Securities Commission (the “OSC”), as Altus Group’s principal regulator, has granted an exemptive relief order exempting Altus Group from com ...

Commercial Lines Insurance Pricing Survey: Q3 2025NEW YORK, Dec. 15, 2025 (GLOBE NEWSWIRE) -- U.S. commercial insurance rates remained at a 3.8% increase in the third quarter of 2025, continuing the downward trend from the previous two quarters (3.8% in Q2 2025 and 5.3% in Q1 2025), according to the latest findings from WTW's Commercial Lines Insurance Pricing Survey (CLIPS). The survey compares premiums for policies underwritten in a given quarter compared with the same coverage lines in the prior year, pr ...

HOUSTON, Dec. 15, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced it has entered into definitive agreements for the issuance and sale of an aggregate of 5,227,275 shares of its common stock at an offering price of $0.33 per share ...

Highlights: 18-month development collaboration with the Department of the Navy has demonstrated Amaero’s strong technical capability in PM-HIP manufacturing of near-net-shape parts, including notable advances in material behavior modeling, geometric precision and process advances.The Navy recognizes PM-HIP as a mature and well-established process covered by existing military specifications and robust process understanding.PM-HIP is positioned as a promising option in addressing long lead time and capacity ...

SOMERSET, N.J., Dec. 15, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leading provider of AI-driven healthcare technology solutions for medical practices and health systems nationwide, today announced the full launch of stratusAI Desk Agent™, an agentic AI phone receptionist designed to modernize and automate patient phone interactions. stratusAI Desk Agent brings advanced conversational AI directly into the call center workflow, eliminating hold times and ...

Purpose-built for compliance, complexity and conversion, EuroOptic’s new site showcases the power of the full Commerce portfolio of BigCommerce, Feedonomics and MakeswiftAUSTIN, Texas, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Commerce (Nasdaq: CMRC), an open, intelligent ecosystem of technology solutions that empower businesses to unlock data potential and deliver seamless, personalized experiences at scale, today announced the launch of EuroOptic, a specialist retailer of high-end optics and precision sporting ge ...

LEHI, Utah, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Synergy Worldwide, a division of Nature’s Sunshine Products, today announced that Euromonitor International has named Pro-Argi-9+ the world’s #1 l-arginine supplement,* reinforcing the product’s growing global momentum and Synergy’s leadership in the health and wellness space. Synergy’s flagship product, Pro-Argi-9+ offers a unique formula with clinically researched ingredients featuring L-Arginine to support nitric oxide production and promote healthy circulati ...